Ricolinostat
Study of Ricolinostat in Patients With Diabetic Neuropathy Pain

Type of Study:
Interventional, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study

Study Length:
28 Days

Target Age/Sex:
18 Years and older

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov

Staus: Enrolling

Description:

This is a randomized, double-blind, parallel group clinical study designed to evaluate the safety and efficacy of ricolinostat for painful diabetic neuropathy.

Enroll Now

Enroll Now

Address
Address
City
State/Province
Zip/Postal
If you don't have a primary care physician, just type "Do not have a primary care physician"